O0122 ENDOSCOPIC GASTROPLICATION FOR THE TREATMENT OF PAEDIATRIC GASTRO-OESOPHAGEAL REFLUX DISEASE: 12 MONTH FOLLOW UP RESULTS
Rattachement africain : gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction: The aim of this work is to assess the medium term efficacy of the BARD Endocinch© device for the treatment of gastro-oesophageal reflux disease (GORD) in children and adolescents. Methods: 17 (5 male) consecutive children - age 12.4 yrs (6.1–15.9), weight 46.0 kg (16.5–87.5) with symptoms of GORD dependent on PPIs for >12 months or refractory to PPIs underwent endoscopic gastroplication (EG), and follow up occurred for a median of 15 months. Symptom scoring, upper GI endoscopy, oesophageal manometry (in 4), gastric scintiscan, 24 hour oesophageal pH, and completed reflux quality of life (QOLRAD) were at 0, 6 and 52 weeks. Repeat 24 hour pH was performed at 2 (n=17) and 12 (n=9) months. Results: Median duration of the procedure for 3 plications was 65 minutes. Improvement in heartburn (p=0.001), regurgitation (p=0.002,) and nausea score (frequency ×severity) (p=0.013) was sustained at 12 months. Total, and all sub-parameters, of QOLRAD showed sustained improvement. Total QOLRAD (max 175) increased from median 101 (range 71–149) to165.6 (range 106.6–175) (p<0.0002) at 6 weeks follow up, and 153 (range 111–175) (p=0.001) 12 months. All pH parameters improved significantly. Median reflux index from 16.65% (0.9–67.9%) to 2.5% (0.7–15.7%) (p=0.001) at 6 weeks, and 4.3% (2.2–20.6) (p=0.02) at 12 months. DeMeester scores from 73 (6.1–258) to 11.95 (2.6–59.9) (normal<14.72) (p=0.002) at 6 weeks, and 19.2 (11–41.4) (p=0.018) at 12 months. 14/17 did not require any further PPI use at any stage. One patient had localized gastric bleeding requiring red cell transfusion. Conclusion: This is the first study reporting paediatric experience with an endoscopic anti-reflux procedure and demonstrates medium term sustained efficacy in managing GORD in children.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- O0122 ENDOSCOPIC GASTROPLICATION FOR THE TREATMENT OF PAEDIATRIC GASTRO-OESOPHAGEAL REFLUX DISEASE: 12 MONTH FOLLOW UP RESULTS
- Date Crossref
- 01/06/2004
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.